China kicks off special bond sale as tariffs threaten economy
[NEW YORK] China issued the first batch of special sovereign bonds for the year on Thursday (Apr 24) as part of the stimulus announced by authorities to soften the blow from simmering trade tensions with the US.
The Ministry of Finance issued a three-part special sovereign bonds which had a planned size of 286 billion yuan (S$51.6 billion). The bond sale is to fund the fiscal package approved in March, but unlike sovereign debt, special bonds are issued for specific purposes and are not accounted for in China's record high fiscal deficit target of 4 per cent for the year.
The latest round of issuance comes as Beijing looks to ramp up spending to defend the economy from the onslaught of 145 per cent US tariffs on Chinese goods, which can make Beijing's 5 per cent growth target for 2025 hard to achieve.
'The government is accelerating the pace of fiscal policy support to offset the tariff shock,' said Zhaopeng Xing, senior strategist at Australia & New Zealand Banking Group. 'We expect a supply peak in the next couple of months and People's Bank of China (PBOC) will keep liquidity steady.'
Thursday's issuance consisted of 165 billion yuan of five-year special bonds for bank capital injection as state-owned banks struggle with thin profit margins amid the economic malaise. China plans to sell a total of 500 billion yuan of such bonds by Jun 4.
The five-year notes were sold at an average yield of 1.45 per cent, according to a trader who bids at the government debt auctions.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Also on offer on Thursday were 50 billion yuan and 71 billion yuan of 20- and 30-year special bonds, respectively. Those are part of the 1.3 trillion yuan of 20-, 30- and 50-year ultra-long special sovereign notes that will be offered through October.
The total issuance quota of ultra-long special sovereign bonds this year is higher than the one trillion yuan sold last year. Proceeds from the sale will be used for financing consumer goods purchases, building major infrastructure projects and encouraging businesses to update equipment.
The 20-, 30-year notes were priced at 1.98 and 1.88 per cent, respectively, said the trader who isn't allowed to speak publicly. The bid-to-cover ratio for these bonds exceeded three times, in a sign of strong investor demand, the trader said.
The special bond issuance results were in line with market expectations, said Zhaopeng Xing, senior strategist at Australia & New Zealand Banking Group. 'The government is accelerating the pace of fiscal policy support to offset the tariff shock.'
Despite the impending supply of bonds, the market is showing no signs of stress as some expect the PBOC to cut interest rates or the amount of cash banks must keep in reserve this year to bolster growth. The benchmark 10-year bond yield was just around five basis points shy of a record low touched in February.
China's overnight repo rate hovered around 1.6 per cent on Thursday, the lowest since January, in a sign of ample cash levels to help cushion the increased debt supply.
'We expect a supply peak in the next couple of months and People's Bank of China will keep liquidity steady,' said ANZ's Xing.
The PBOC may use tools such as outright reverse repurchase agreements to manage liquidity, ANZ's Xing said. 'It could also consider resuming buying of government bonds or cutting the required reserve ratio to inject liquidity at proper time.' BLOOMBERG
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
3 hours ago
- Business Times
Perennial explores Reit listings in China with ‘aggressive' expansion in medical, eldercare sectors
[SINGAPORE] Property player Perennial Holdings is exploring real estate investment trust (Reit) listings in China – one for commercial properties and another for healthcare assets, the company's chief executive, Pua Seck Guan, told The Business Times. The Reits, which could be listed in Shanghai or Shenzhen, would ride on booming demand from yield-hungry investors on the mainland. 'The Chinese love this class of assets. If you go and do a check today, the Chinese Reit yield is below 5 per cent; in Singapore, it's more than 7 per cent,' said Pua in an interview at the company's one-north office. With deposit rates under 1 per cent, Chinese investors are hunting for dividends. 'So if you give them 4 to 5 per cent (in yield), they will be very happy,' the CEO said, adding that there is demand from both retail and institutional investors. Founded in 2009, Perennial has five healthcare-centric mega developments in China – in Chengdu, Kunming, Xi'an, Chongqing and Tianjin – and a commercial-focused one in Hangzhou, among other assets. It also operates China's first fully foreign-owned hospital in Tianjin, has another coming up in Guangzhou, and is invested in major eldercare company Renshoutang. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Reits were introduced in China in 2021, and demand has been 'stratospheric', according to a Bloomberg report in February. There were 28 Reits listed in China last year – nearly trebling from the number in 2023 – which raised a record 64 billion yuan (S$11.4 billion). Perennial may also consider listing its healthcare business in Hong Kong or mainland China, said Pua. The company, which traded on the Singapore Exchange from 2014 to 2020, has no plans to pursue listings here. Pua cited liquidity and valuations as concerns, along with the fact that the majority of Perennial's business is now in China. The company began its foray into China healthcare a decade ago with the opening of a medical hub in Chengdu. It now owns and operates more than 25,000 beds in medical and eldercare facilities in Singapore and China. In Singapore, Perennial, together with Far East Organization, is redeveloping Golden Mile Complex. There will be medical suites, offices, retail spaces and a residential tower. The company is also heading a consortium that is redeveloping the former AXA Tower in Shenton Way. A patient at the Perennial Rehabilitation Hospital in Tianjin. PHOTO: ST First-mover advantage Perennial's listing plans come on the back of big ambitions to expand in China's medical and eldercare sectors. In late 2024, it announced the 500-bed Perennial General Hospital Tianjin, the first such facility to be fully foreign-owned in China, with a one billion yuan investment. Months later, it inked a deal to build a second fully foreign-owned hospital in Guangzhou, also with a one billion yuan investment. Perennial is now concluding talks to open another fully foreign-owned hospital in Shanghai, said Pua. Tianjin, Guangzhou and Shanghai are among the nine trial cities where China has allowed fully foreign-owned hospitals to operate, in a pilot announced in September 2024. The other trial cities are Beijing, Nanjing, Suzhou, Fuzhou, Shenzhen and Hainan. Pua hopes to do projects in more than half of these nine cities. 'We think the Chinese medical (sector) is just at a very nascent stage… The market is huge, so we want to seize this opportunity. I think we have a first-mover advantage.' He sees the Chinese authorities being supportive of private operators such as Perennial that can service the medical needs of the upper middle class segment. The company also wants to ride on China's emerging medical tourism industry. It hopes to attract patients from Russia, Central Asia and South-east Asia – including Vietnam, Laos and Cambodia, said Pua. He views Guangzhou as an ideal location for medical tourism, due to its good air connectivity, infrastructure and weather. Perennial's rehabilitation facilities could also be a pull factor, with their combination of Western and traditional Chinese medicine (TCM), he added. That said, he acknowledged that the more challenging part is attracting patients who are willing to undertake surgery, and emphasised the need to build trust and reputation. Dr Daniel Liu, president of Perennial's general hospital in Tianjin, says the company wants to grow medical tourism in China. PHOTO: ST Perennial's Tianjin general hospital aims to have 30 per cent of its revenue come from international patients within its first year, said its president, Dr Daniel Liu. 'Medical tourism can't yet be called an industry in China; there are some signs, but not yet. What we hope to do now is to make this cake bigger,' he said during a tour of the hospital. Dr Liu believes that the hospital could even attract patients from the UK, where waiting times for surgeries are long. Some of China's specialised medical services – such as cardiology, orthopaedics and urology – are competitive with international peers, he said. 'Very aggressive' Perennial is 'actually very aggressive' with its expansion plans, said Tan Bee Lan, the company's healthcare chief executive, on the sidelines of a visit to a Renshoutang facility in Shanghai. Asked about the timing of the moves – amid global uncertainty and weak consumer spending in China – Tan said that she does not see a 'material effect', given the counter-cyclical nature of healthcare. There is also an opportunity to secure assets at attractive valuations. 'You should take projects when no one wants to do them – that is when you get the land, the property, at a very reasonable price… This is what Perennial is doing. We're going around very aggressively, looking at suitable properties to take over,' she said. Tan Bee Lan, Perennial's healthcare chief executive, is sanguine about macroeconomic headwinds. PHOTO: ST Perennial also plans to apply what it has learnt in Tianjin to an upcoming Singapore project: the city-state's first private assisted-living development, for which the company won a tender in June 2023. Said Pua: 'To be honest, it's very, very difficult to make money in Singapore because of the high real estate costs, the high labour costs… But I think being headquartered in Singapore, we thought (it would be) good to do something and (showcase) a model.' 'So this project will contain the ingredients that we have in Tianjin,' he added, citing how the development in Parry Avenue will also integrate eldercare with TCM rehabilitation and a geriatric care centre. With the Tianjin hospital opening more doors, Pua believes that the company is two to three years 'ahead of anybody' in its expansion plans. 'I'm excited,' he said. Perennial's key shareholders include agribusiness Wilmar International – where Pua is also chief operating officer – and Wilmar co-founder Kuok Khoon Hong.

Straits Times
5 hours ago
- Straits Times
Vietnam says US trade talks made progress but key issues are unresolved
FILE PHOTO: A container ship is seen near the Hai Phong International Container Terminal, after U.S. President Donald Trump announced a 90-day pause on tariffs for many countries, in Hai Phong, Vietnam, April 16, 2025. REUTERS/Athit Perawongmetha/File Photo Vietnam says US trade talks made progress but key issues are unresolved HANOI - Vietnam and the United States made progress during a third round of trade negotiations last week, but critical issues remain unresolved, requiring further analysis and continued dialogue, Vietnam's trade ministry said on Sunday. The talks, in Washington, D.C. from June 9-12, were held as a pause on 46% "reciprocal" tariffs on Vietnamese exports approaches expiration in early July, adding pressure on both sides to reach a compromise. Vietnam's trade surplus with the United States surged to $12.2 billion in May, up nearly 42% year-on-year and 17% higher than April, Vietnamese government data showed. Exports to the U.S. climbed 42% from a year earlier to $13.8 billion, hitting a post-pandemic high. U.S. negotiators have submitted a list of trade demands to Hanoi, which Vietnamese officials described as "tough," including measures aimed at reducing Vietnam's reliance on Chinese imports of industrial materials and components. Vietnam's trade ministry said on Sunday the delegations had narrowed gaps on issues outlined in Vietnam's response to the U.S. requests and worked toward mutually acceptable solutions. Both sides agreed to hold an online meeting in the coming days between Vietnam's trade minister Nguyen Hong Dien and U.S. Secretary of Commerce Howard Lutnick to address unresolved issues, the ministry added. The last round of talks was held between Dien, Lutnick and U.S. Trade Representative Jamieson Greer, a format proposed by the United States. Under pressure from Washington, Hanoi has recently cracked down on illegal transshipment - typically when cargo is moved between ships during transit - of goods primarily from China. It has also expressed willingness to lower non-tariff barriers and increase imports of U.S. goods such as planes, farm products, and energy, though no purchase agreements have been announced. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
11 hours ago
- Business Times
Taiwan imposes technology export controls on Huawei, SMIC
Taiwan has blacklisted Huawei Technologies and Semiconductor Manufacturing International Corp (SMIC), dealing another major blow to the two companies spearheading China's efforts to develop cutting-edge AI chip technologies. Taiwan's International Trade Administration has included Huawei, SMIC and several of their subsidiaries in an update of its so-called strategic high-tech commodities entity list, according to the latest version that was made available on its website on Saturday (Jun 14). It didn't publicly announce the change. According to Taiwan's existing regulations, local companies will require approval from the island's government before they can ship anything to users on the entity list. In 2023, Bloomberg News reported that several Taiwanese companies were helping Huawei build infrastructure for an under-the-radar network of chip plants across southern China. The new restrictions imposed by Taipei are likely to at least partially cut off Huawei and SMIC's access to Taiwan's plant construction technologies, materials and equipment essential to build AI semiconductors, such as those made by Taiwan Semiconductor Manufacturing Co (TSMC) for the likes of Nvidia Corp. In Huawei's case, several of its overseas units including in Japan, Russia and Germany were also captured in the update to Taiwan's entity list. Both Huawei and SMIC – and some of their subsidiaries – are also on the US entity list, which has significantly limited the companies' ability to acquire foreign technology. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Huawei and SMIC didn't immediately respond to requests for comment outside of regular office hours. While Taiwan has for years imposed certain blanket bans on the shipments of critical chipmaking equipment including lithography machines to China, it hasn't included leading Chinese tech companies or chipmakers on its entity list previously. TSMC, the go-to chipmaker for Apple and Nvidia, cut off its supplies to Huawei in 2020 because of US export controls. Huawei, together with SMIC, shocked American politicians in 2023 by releasing an advanced, made-in-China 7-nanometre chip. While the two are struggling to improve their technologies due to various curbs, they are still China's best hope to help fill in the AI chip gap left by a lack of Nvidia's most sophisticated semiconductors. Tensions between Taiwan and China also stepped up a notch earlier this year after Taiwan President Lai Ching-te labelled China a 'foreign hostile force' for the first time and unveiled wide-ranging measures to counter infiltration efforts. China claims the self-governing democracy as its territory and has vowed to unify with Taiwan, using force if necessary. BLOOMBERG